Product Information
PILOCARPINE HCL 7.5 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.3368 per EA under NDC 00228283711. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 22, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228283711
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020237FDA Approved
3/22/1994
TE Code
AB
On Market Since
9/13/2011
Pharmacological Classes
Price Statistics
The NADAC for PILOCARPINE HCL 7.5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3368 per EA |
|---|---|
| All-time high | $1.4079 (Dec 14, 2016) |
| All-time low | $0.3028 (Jun 17, 2026) |
| 52-week high | $0.4379 |
| 52-week low | $0.3028 |
| Median price | $1.1129 |
| Average price | $0.9484 |
| Largest weekly change | +57.7% (Feb 23, 2022) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pilocarpine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PILOCARPINE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PILOCARPINE HCL 7.5 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.3368 per EA (NDC 00228283711), effective Aug 19, 2026.
How has the price of PILOCARPINE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PILOCARPINE HCL 7.5 MG TABLET has declined 70.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PILOCARPINE HCL 7.5 MG TABLET?
Since Nov 28, 2013, the NADAC for PILOCARPINE HCL 7.5 MG TABLET has ranged from a low of $0.3028 (Jun 17, 2026) to a high of $1.4079 (Dec 14, 2016), with a median of $1.1129 per EA.
Are there cheaper alternatives to PILOCARPINE HCL 7.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PILOCARPINE HCL 7.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PILOCARPINE HCL 7.5 MG TABLET?
PILOCARPINE HCL 7.5 MG TABLET (NDC 00228283711) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.